Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
Immunome Inc (NASDAQ: IMNM) closed the day trading at $16.35 up 15.96% from the previous closing price of $14.1. In other words, the price has increased by $15.96 from its previous closing price. On the day, 2.1 million shares were traded. IMNM stock price reached its highest trading level at $16.4 during the session, while it also had its lowest trading level at $13.935.
Ratios:
For a better understanding of IMNM, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.13 and its Current Ratio is at 12.13. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Goldman on September 22, 2025, initiated with a Buy rating and assigned the stock a target price of $26.
On September 05, 2025, Craig Hallum started tracking the stock assigning a Buy rating and target price of $26.
On April 02, 2025, Lake Street started tracking the stock assigning a Buy rating and target price of $23.Lake Street initiated its Buy rating on April 02, 2025, with a $23 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 03 ’25 when BIENAIME JEAN JACQUES bought 5,000 shares for $9.38 per share. The transaction valued at 46,900 led to the insider holds 36,415 shares of the business.
BIENAIME JEAN JACQUES bought 7,800 shares of IMNM for $60,684 on Mar 25 ’25. The Director now owns 31,415 shares after completing the transaction at $7.78 per share. On Mar 26 ’25, another insider, SIEGALL CLAY B, who serves as the President and CEO of the company, bought 137,100 shares for $7.29 each. As a result, the insider paid 999,459 and bolstered with 806,736 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMNM now has a Market Capitalization of 1423185920 and an Enterprise Value of 1159291904. For the stock, the TTM Price-to-Sale (P/S) ratio is 113.04 while its Price-to-Book (P/B) ratio in mrq is 5.28. Its current Enterprise Value per Revenue stands at 92.088 whereas that against EBITDA is -6.153.
Stock Price History:
The Beta on a monthly basis for IMNM is 1.92, which has changed by 0.16625309 over the last 52 weeks, in comparison to a change of 0.14201736 over the same period for the S&P500. Over the past 52 weeks, IMNM has reached a high of $15.12, while it has fallen to a 52-week low of $5.15. The 50-Day Moving Average of the stock is 51.62%, while the 200-Day Moving Average is calculated to be 71.89%.
Shares Statistics:
Over the past 3-months, IMNM traded about 1.19M shares per day on average, while over the past 10 days, IMNM traded about 1467920 shares per day. A total of 87.01M shares are outstanding, with a floating share count of 79.76M. Insiders hold about 8.37% of the company’s shares, while institutions hold 85.10% stake in the company. Shares short for IMNM as of 1759190400 were 15469351 with a Short Ratio of 12.96, compared to 1756425600 on 13564861. Therefore, it implies a Short% of Shares Outstanding of 15469351 and a Short% of Float of 18.56.
Earnings Estimates
The company has 9.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.56, with high estimates of -$0.45 and low estimates of -$0.73.
Analysts are recommending an EPS of between -$1.74 and -$2.4 for the fiscal current year, implying an average EPS of -$2.09. EPS for the following year is -$2.36, with 9.0 analysts recommending between -$1.63 and -$2.79.
Revenue Estimates
A total of 11 analysts have provided revenue estimates for IMNM’s current fiscal year. The highest revenue estimate was $16M, while the lowest revenue estimate was $6.9M, resulting in an average revenue estimate of $8.54M. In the same quarter a year ago, actual revenue was $9.04M
